Study of liver problems after stem cell transplant
Part of Digestive system clinical trials.
This study looks at how often liver problems happen and how they develop in people being evaluated for a stem cell transplant. It may help doctors predict and better manage liver complications during and after transplant care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older, or be a child ages 3–17
- Be at the NIH Clinical Center for evaluation for a hematopoietic stem cell transplant
- Be able to take part in all study procedures
- Be able to give written informed consent (or have a parent/guardian consent for minors)
- Not be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people getting a stem cell transplant to watch for lung problems, like infections or other lung diseases, that can happen after the transplant. The goal is to catch these issues early.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
This study follows people who are at least 3 years out from their first stem cell transplant to learn how they are doing long term. It may help improve future transplant care by tracking outcomes over time.
This study looks at how too much iron in the body (from past transfusions) affects the liver in people who had a stem cell transplant at least 10 years ago. It will help doctors understand who needs special monitoring for liver problems.
This study follows patients who have had a stem cell transplant to see how their heart and blood vessels are doing over time. It helps doctors learn about long-term heart risks after transplant.
Hear when a new Hematopoietic Stem Cell Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.